Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome
- 1 October 2011
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 141 (1) , 103-110
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NIH) (AI071180-02, N01-AI-65308)
- Intramural Research Program of the NIH
This publication has 30 references indexed in Scilit:
- Anti-Borrelia burgdorferi Antibody Profile in Post-Lyme Disease SyndromeClinical and Vaccine Immunology, 2011
- HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20low expressing tumor cells that resist rituximab-mediated lysisHaematologica, 2010
- Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptomsBrain, Behavior, and Immunity, 2010
- Chronic Lyme Disease: A ReviewInfectious Disease Clinics of North America, 2008
- A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathyNeurology, 2008
- Dominant Epitopes of the C6 Diagnostic Peptide ofBorrelia burgdorferiAre Largely Inaccessible to Antibody on the Parent VlsE MoleculeClinical and Vaccine Immunology, 2007
- The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006
- Crystal Structure of Lyme Disease Variable Surface Antigen VlsE of Borrelia burgdorferiJournal of Biological Chemistry, 2002
- C-Terminal Invariable Domain of VlsE Is Immunodominant but Its Antigenicity Is Scarcely Conserved among Strains of Lyme Disease SpirochetesInfection and Immunity, 2001
- Epitope Mapping of the Immunodominant Invariable Region ofBorrelia burgdorferiVlsE in Three Host SpeciesInfection and Immunity, 2000